Vinge Logotype
Svenska English 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Transtema in connection with listing on Nasdaq Stockholm
Mandate

Vinge advises Transtema in connection with listing on Nasdaq Stockholm

September 17, 2021 Banking and Finance Capital Markets and Public M&A Employment and Benefits Intellectual Property IT, Telecommunications and Outsourcing

Vinge has advised Transtema in connection with its application for admission to trading on Nasdaq Stockholm’s main list.

The Nasdaq Companies Committee approved the application on 17 September 2021, and Transtema published the prospectus on the same day. The first day of trading is planned to take place on 29 September.

Vinge’s team primarily consisted of Anders Strid, Edin Agic (Project Manager), Jacob Benzov, Lina André (Banking and Finance), Anna Backman (Employment Law), Alexander Lindeberg (IP/IT) and Anna Högsten (IP/IT)

Related

Vinge advises Isofol Medical AB (publ) in connection with its rights issue of units

Through the rights issue of units, consisting of shares and warrants, and the exercised over-allotment issue, Isofol will receive approximately SEK 84 million and may receive an additional maximum of approximately SEK 110 million upon exercise of all warrants at the highest subscription price.
August 01, 2025

Vinge advises Oncorena in connection with share issue

 Vinge advises Oncorena Holding AB in connection with a share issue of approximately SEK 133 million.
July 30, 2025

Vinge advises Karl Hedin and minority owners on the sale of AB Karl Hedin Sågverk to Vida

 Vinge has advised Karl Hedin and minority shareholders in connection with the sale of AB Karl Hedin Sågverk to Vida Aktiebolag (“Vida”).
July 24, 2025